1[1]Lu J,Chua HH,Chen SY,et al.Regulation of matrix metallopoteinass-1 by Epstein-Barr virus proteins[J].Cancer Res,2003,63(1):256～262.
2[2]Watanabe H,Iwase M,Ohashi M,et al.Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines[J].Oral oncol,2002,38(7):670～679.
3[3]Moilanen M,pirila E,Grenman,R,et al.Expression and regulation of collagenase-2(MMP-8)in head and neck squamous cell carcinomas[J].J pathol,2002,197(1):72～81.
4[4]Mannello F.Cirulating 92-kildalton matrix metalloproteinase (MMP-9)activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma[J].Cancer,2003,97(1):201～203.
5[5]Nathan CA,Amirghahri N,Rice C,et al.Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients[J].Laryngoscope,2002,112(12):2129～2140.
6[6]Munshi HG,Wu YI,Ariztia EV,et al.Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells[J].J Biol chem,2002,277(44):41480～41488.
7[7]Thomas GJ,Lewis MP,Hart IR,et al.Binding of TGF-betal latency-associated peptide(LAP)to alpha(v) beta6 integrin modulates behaviour of squamous carcinoma cells[J].Int J Cancer,2001,92(5):641～650.
8[8]Sternlicht MD,Bissell MJ,Werb Z.The matrix matalloproteinase stromelysin-1 acts as a natural mammary tumor promoter[J].Oncogene,2000,21(18):1102～1113.
9[9]Aznavoorian S,Moore BA,ALexander-Lister LD,et al.Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells[J].Cancer Res,2001,61(16):6264～6275.
10[10]Giavazzi R,Taraboletti G.Preclinical development of metalloproteasis in cancer therapy[J].Oncol Hematol,2001,37(1):53～60.
同被引文献23
1Kanayama H O, Yokota K, Kurokawa Y, et al. Prognostic values of matrixmetalloproteinase-2 and tissue inhibitor of metallproteinase-2 expression in bladder cancer [J]. Cancer, 1998,82(7) : 1359.
2Kahari V M, Saarialho-Kere U. Matrix metallop roteinases and their inhibitor in tumor growth and invasion [J]. Ann Med, 1999,31 (1) : 34.
3Grignon D J, Sakr W, Toth M, et al. High levels of tissue inhabtitor of metallproteinase-2 (TIMP-2) exprerssion are associated with poor outcome in invasive bladder cancer [J]. Cancer Res, 1996,56(7) : 1654-1659.
4Murray G I. Matrix metal|op roteinases: a multifunctional group ofmolecules [J]. J Pathol, 2001,195(2) : 135.
5Herrea C A, Xu L, Bucana C D, et al. Expression of metastasis related genes in human epithelial ovarian tumors [J]. Int J Oncol, 2002,20(1) :5-13.
6Juan C, Manuel F, Lucas V, et al. Expression and clinical signifcance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma [J]. Oral Oncology, 2005,41 (3) : 283-293.
7Montjean F, Evrard L, Magremanne M, et al. Oral verrucous carcinoma [J]. Rev Med Brux, 2004,25(3) : 173-177.
9[3]Schirrmacher V,Griesbach A,Ahlert T.Antitumor effects of Newcastle Disease Virus in vivo:local versus systemic effects[J].Int J Oncol,2001,18(5) :945～952.
10[4]Zorn U,Dallmann l,Grosse J,et al.Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus[J].Cancer Biother,19 94,9(3):225～235.
